Source: Cochrane Library
Area: Evidence > Disease Focused Reviews
Background
Eye movement disorders may affect over 70% of stroke patients. These eye movement disorders can result in difficulty maintaining the normal ocular position and difficulty…
Month: October 2011
Interventions for visual field defects in patients with stroke
Source: Cochrane Library
Area: Evidence > Disease Focused Reviews
Background
Visual field defects are estimated to affect 20% to 57% of people who have had a stroke. Visual field defects can affect functional ability in activities of daily living …
Canon’s TX-20 Non-Contact Tonometer Cleared in U.S.
Canon has received FDA 510(k) clearance for the TX-20 full-auto non-contact tonometer.The device can be used with a touch of one button when in fully automatic mode, or a peak intraocular pressure (IOP) can be set so that the device issues a warning me…
Final ACO Regulations Released: Now More Physician-Friendly
CMS has lowered the number of quality measures for accountable care organizations from 65 to 33, in just one simplification made in response to complaints by organized medicine. Medscape Medical News
Highlights From ESCRS 2011
Dr. Roger Steinert offers his insights on the recent European Society of Cataract & Refractive Surgeons meeting. What are the anticipated latest advances and developments? Medscape Ophthalmology
CWRU to lead Cornea Preservation Time Study
Researchers at Case Western Reserve University School of Medicine will lead a national study determining if corneas transplanted up to two weeks after donor death work as well as corneas transplanted up to one week after donor death. The National Eye I…
Vision Scientists And FDA Discuss Endpoint Measures For Assessing Glaucoma Therapies
The vision research community is discussing with the Food and Drug Administration (FDA) how to adopt and/or implement safe and effective endpoint measures for assessing glaucoma therapies in U.S. clinical trials…
Steroids Could Help Heal Some Corneal Ulcers
A UCSF study gives hope to those suffering from severe cases of bacterial corneal ulcers, which can lead to blindness if left untreated. The use of topical corticosteroids in a randomized controlled trial was found to be neither beneficial nor harmful …
Whether We Know It Or Not, We Can "See" Through One Eye At A Time
Although portions of the visible world come in through one eye only, the brain instantaneously takes all that information and creates a coherent image. As far as we know, we “see” with both eyes at once. Now a new study suggests that the brain may know…
Highlights From ESCRS 2011
iTunes conversion to RSS provided by Feed Flipper: [Web] – [Facebook] – [Donate!]
Dr. Roger Steinert offers his insights on the recent European Society of Cataract & Refractive Surgeons meeting. What are the anticipated latest advances and…
Lux Biosciences GmbH withdraws marketing authorisation application for voclosporin (Luveniq)
Source: European Medicines Agency (EMA)
Area: News
The European Medicines Agency (EMA) has announced that it has been formally notified by Lux Biosciences GmbH of its decision to withdraw its application for a centralised marketing authorisation for t…
Watson, Can You Heal Me Now? Physicians Are Talking
In this discussion, physicians talk about Watson — IBM’s artificial intelligence system that beat Jeopardy! contestants and is now being used at an insurance company to aid in diagnosis. Medscape Family Medicine
IRIDEX introduces optional MicroPulse module
IRIDEX Corporation announced today that it has expanded its product offering by introducing an optional MicroPulse module in the Company’s IQ532 (green) laser system and now provides a complete portfolio of infrared, yellow and green laser systems whic…
Oxford BioMedica Announces US IND Approval For Novel Ocular Product In Usher Syndrome Type 1B
Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE: OXB), the leading gene-based biopharmaceutical company, announces that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for the Phase …
Topical corticosteroids show promise against bacterial corneal ulcers
A UCSF study gives hope to those suffering from severe cases of bacterial corneal ulcers, which can lead to blindness if left untreated. The use of topical corticosteroids in a randomized controlled trial was found to be neither beneficial nor harmful …
October is the AAO Meeting
The American Academy of Ophthalmology starts this week. I will be going to learn about the latest in retinal disease, but also will be teaching…about marketing.
Steroids Help Patients With Worst Corneal Ulcers
Topical corticosteroids can improve visual acuity in patients with severe corneal ulcers, a team of US and Indian researchers has found. Reuters Health Information
MeReC Rapid Review: Most people with acute infective conjunctivitis don’t need antibiotics
Source: NPC
Area: News
The National Prescribing Centre has published a MeReC Rapid Review discussing the results of a meta-analysis that found a small overall significant benefit of topical antibiotics in acute infective conjunctivitis; however no sig…
Gene Therapy Update 1: First Clinical Trial for a Form of Retinitis Pigmentosa (RP) Approved to Begin
In an announcement today, Oxford BioMedica said that it had gained approval from the FDA to begin a Phase I/IIa Clinical Trial for a form of Usher’s Syndrome, Type 1B, which leads to progressive retinitis pigmentosa combined with a congenital hearing…
EU marketing authorisation application for voclosporin (Luveniq®) withdrawn
Source: European Medicines Agency
Area: News
The European Medicines Agency (EMA) has announced the withdrawal of the application for a centralised marketing authorisation for voclosporin (Luveniq®), which was intended to be used for the treatment of…